| 51 | 9323080 | Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening. | Circulation | 1997 Sep 16 |
3 |
| 52 | 9331000 | Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers. | J Hum Hypertens | 1997 Sep |
1 |
| 53 | 9331006 | Inhibition of angiotensin II pressor response and ex vivo angiotensin II radioligand binding by candesartan cilexetil and losartan in healthy human volunteers. | J Hum Hypertens | 1997 Sep |
2 |
| 54 | 9362249 | Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy. | Am J Physiol | 1997 Oct |
1 |
| 55 | 9368701 | Effects of the new angiotensin receptor antagonist dipotassium (Z)-2-[[5-ethyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl] methyl-1,3,4-thiadiazoline-2-ylidene]aminocarbonyl]-1-cy clopentencarbox ylate on experimental cardiac hypertrophy and acute left ventricular failure. | Arzneimittelforschung | 1997 Oct |
1 |
| 56 | 9407461 | Nitric oxide synthase I immunoreactivity in the macula densa of the kidney is angiotensin II dependent. | Kidney Int Suppl | 1997 Dec |
3 |
| 57 | 9689152 | Hypotensive effects of an angiotensin II type 1 receptor antagonist differ between exercised and sedentary rats aged from 4 to 19 weeks. | Jpn J Physiol | 1998 Jun |
1 |
| 58 | 9754919 | Possible mechanism for the anemia induced by candesartan cilexetil (TCV-116), an angiotensin II receptor antagonist, in rats. | Eur J Pharmacol | 1998 Aug 7 |
1 |
| 59 | 9793068 | [Pathophysiological significance of the natriuretic peptide system: receptor subtype as another key factor]. | Nihon Yakurigaku Zasshi | 1998 Sep |
1 |
| 60 | 9804061 | Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats. | Jpn J Pharmacol | 1998 Sep |
1 |
| 61 | 9829158 | Candesartan cilexetil. A review of its use in essential hypertension. | Drugs | 1998 Nov |
1 |
| 62 | 9841488 | Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats. | Am J Physiol | 1998 Jun |
1 |
| 63 | 9853001 | Role of angiotensin II, endothelin-1, and nitric oxide in HgCl2-induced acute renal failure. | Toxicol Appl Pharmacol | 1998 Oct |
1 |
| 64 | 9892160 | Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats. | J Am Soc Nephrol | 1999 Jan |
2 |
| 65 | 10076923 | Effects of candesartan cilexetil on oxidative state and renal function in 5/6 nephrectomized rats. | J Hum Hypertens | 1999 Jan |
1 |
| 66 | 10076925 | Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action. | J Hum Hypertens | 1999 Jan |
1 |
| 67 | 10087246 | Serial changes in sarcoplasmic reticulum gene expression in volume-overloaded cardiac hypertrophy in the rat: effect of an angiotensin II receptor antagonist. | Clin Sci (Lond) | 1999 Apr |
1 |
| 68 | 10192757 | Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function. | Eur J Clin Pharmacol | 1999 Feb |
1 |
| 69 | 10202848 | Inhibition of the angiotensin II Type 1 receptor by TCV-116: quantitation by in vitro autoradiography. | Jpn J Pharmacol | 1999 Feb |
4 |
| 70 | 10205231 | Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography. | Hypertension | 1999 Apr |
1 |
| 71 | 10232498 | Effect of angiotensin II receptor antagonism on vascular hypertrophy and aortic impedance in abdominal aortic-banded rat. | Am J Hypertens | 1999 Apr |
1 |
| 72 | 10361885 | Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog. | Jpn J Pharmacol | 1999 Apr |
3 |
| 73 | 10390609 | A new class of diacidic nonpeptide angiotensin II receptor antagonists: candesartan cilexetil. | Curr Pharm Des | 1999 Jun |
1 |
| 74 | 10404959 | Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan. | J Hypertens | 1999 Apr |
1 |
| 75 | 10419064 | Effects of chronic oral treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in ventrolateral medulla of SHR. | J Hypertens | 1999 Jul |
4 |
| 76 | 10533806 | A new class of diacidic nonpeptide angiotensin II receptor antagonists: candesartan cilexetil. | Drug Des Discov | 1999 Aug |
1 |
| 77 | 10547078 | Overexpression of insulin-like growth factor-I in hearts of rats with isoproterenol-induced cardiac hypertrophy. | J Cardiovasc Pharmacol | 1999 Nov |
1 |
| 78 | 10579749 | Pharmacological properties of angiotensin II receptor antagonists. | Can J Cardiol | 1999 Nov |
1 |
| 79 | 10588088 | Angiotensin II receptor blockers: review of the binding characteristics. | Am J Cardiol | 1999 Nov 18 |
1 |
| 80 | 10652187 | Angiotensin blockade inhibits SIF DNA binding activities via STAT3 after myocardial infarction. | J Mol Cell Cardiol | 2000 Jan |
1 |
| 81 | 10701823 | Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group. | Am J Hypertens | 2000 Feb |
2 |
| 82 | 10716475 | Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. | J Am Coll Cardiol | 2000 Mar 1 |
3 |
| 83 | 10750588 | Role of the renin-angiotensin system in cardiac hypertrophy. | Am J Cardiol | 1999 Jun 17 |
1 |
| 84 | 10774787 | Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats. | J Cardiovasc Pharmacol | 2000 Apr |
1 |
| 85 | 10826401 | Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. | Am J Hypertens | 2000 May |
1 |
| 86 | 10836729 | Differential effects of imidapril and candesartan cilexetil on plasminogen activator inhibitor-1 expression induced by prolonged inhibition of nitric oxide synthesis in rat hearts. | J Cardiovasc Pharmacol | 2000 Jun |
3 |
| 87 | 10876800 | [Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist]. | Nihon Yakurigaku Zasshi | 2000 Mar |
1 |
| 88 | 10965089 | Hemodynamic and hormonal effects of the angiotensin II antagonist, candesartan cilexetil, in patients with congestive heart failure. | Cardiology | 2000 |
1 |
| 89 | 10968199 | Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats. | Hypertens Res | 1996 Jun |
1 |
| 90 | 10981551 | In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan. | Am J Hypertens | 2000 Sep |
2 |
| 91 | 10988281 | Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension. UK and Israel Candesartan Investigators. | Hypertension | 2000 Sep |
1 |
| 92 | 11059630 | Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetil. | Blood Press Suppl | 2000 |
1 |
| 93 | 11059631 | Improving antihypertensive efficacy while maintaining placebo-like tolerability. | Blood Press Suppl | 2000 |
1 |
| 94 | 11059633 | Efficacy and tolerability of candesartan cilexetil in special patient groups. | Blood Press Suppl | 2000 |
1 |
| 95 | 11059637 | Exploring new treatment strategies in heart failure. | Blood Press Suppl | 2000 |
1 |
| 96 | 11081784 | A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators. | J Hypertens | 2000 Nov |
1 |
| 97 | 11086231 | Differential effect of chronic inhibition of calcium channel and angiotensin II type 1-receptor on aldosterone synthesis in spontaneously hypertensive rats. | J Steroid Biochem Mol Biol | 2000 Oct |
3 |
| 98 | 11086634 | Putting the efficacy of candesartan cilexetil into perspective: a review of new comparative data. | J Hum Hypertens | 2000 Oct |
1 |
| 99 | 11162135 | Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. | J Mol Cell Cardiol | 2001 Feb |
2 |
| 100 | 11193378 | [Angiotensin II receptor antagonists: candesartan cilexetil]. | Yakugaku Zasshi | 2000 Dec |
1 |